United States · FDA National Drug Code directory

Dizziness HP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
44911-0187_f02fda13-544f-409a-bb7b-038d49cf4932
Product NDC
44911-0187
Form
LIQUID
Composition / generic term
Calcarea carbonica, Chenopodium anthelminticum, Cocculus indicus, Conium maculatum, Nux vomica, Phosphorus, Pulsatilla (pratensis), Silicea, Tabacum,
Labeler
Energique, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20150708
Source listing expiry
20261231

Source-listed ingredients

  • OYSTER SHELL CALCIUM CARBONATE, CRUDE — 30 [hp_X]/mL
  • DYSPHANIA AMBROSIOIDES — 30 [hp_X]/mL
  • ANAMIRTA COCCULUS SEED — 30 [hp_X]/mL
  • CONIUM MACULATUM FLOWERING TOP — 30 [hp_X]/mL
  • STRYCHNOS NUX-VOMICA SEED — 30 [hp_X]/mL
  • PHOSPHORUS — 30 [hp_X]/mL
  • PULSATILLA PRATENSIS WHOLE — 30 [hp_X]/mL
  • SILICON DIOXIDE — 30 [hp_X]/mL
  • TOBACCO LEAF — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (44911-0187-1) · 44911-0187-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →